These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9685916)
1. Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide. Hong SS; Lee SH; Lee YJ; Chung SJ; Lee MH; Shim CK J Control Release; 1998 Feb; 51(2-3):185-92. PubMed ID: 9685916 [TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro evaluation of a solid dispersion system of gliclazide:PEG 6000. Asyarie S; Rachmawati H PDA J Pharm Sci Technol; 2007; 61(5):400-10. PubMed ID: 18047178 [TBL] [Abstract][Full Text] [Related]
3. In-vitro and in-vivo correlation for two gliclazide extended-release tablets. Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192 [TBL] [Abstract][Full Text] [Related]
4. Bioequivalence study of generic gliclazide and Diamicron formulations in healthy Thai male volunteers. Rojanasthien N; Sugunta C; Rungapinan S; Kumsorn B; Sangdee C Int J Clin Pharmacol Ther; 2003 Jul; 41(7):323-30. PubMed ID: 12875349 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects. Cho HY; Yoon H; Lim YC; Lee YB Int J Clin Pharmacol Ther; 2009 Dec; 47(12):770-9. PubMed ID: 19954716 [TBL] [Abstract][Full Text] [Related]
6. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system. Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166 [TBL] [Abstract][Full Text] [Related]
7. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers. Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557 [TBL] [Abstract][Full Text] [Related]
8. Complete bioavailability and lack of food-effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers. Delrat P; Paraire M; Jochemsen R Biopharm Drug Dispos; 2002 May; 23(4):151-7. PubMed ID: 12015789 [TBL] [Abstract][Full Text] [Related]
9. Bioequivalence evaluation of two brands of gliclazide 80 mg tablets (Glyzide & Diamicron)--in healthy human volunteers. Najib N; Idkaidek N; Beshtawi M; Bader M; Admour I; Alam SM; Zaman Q; Dham R Biopharm Drug Dispos; 2002 Jul; 23(5):197-202. PubMed ID: 12116051 [TBL] [Abstract][Full Text] [Related]
10. Trials of clear aceclofenac-loaded soft capsules with accelerated oral absorption in human subjects. Yong CS; Oh YK; Lee KH; Park SM; Park YJ; Gil YS; Yu CH; Yoo BK; Woo JS; Kim JO; Rhee JD; Kim CK; Choi HG Int J Pharm; 2005 Sep; 302(1-2):78-83. PubMed ID: 16107306 [TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical availability of gliclazide from selected matrix formulation tablets. Hermann TW; Dobrucki R; Piechocki S; Resztak M; Reh R Med Sci Monit; 2005 Jun; 11(6):BR181-188. PubMed ID: 15917713 [TBL] [Abstract][Full Text] [Related]
12. A bioequivalence study of gliclazide based on quantification by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry. Mendes GD; Moreira LD; Pereira Ados S; Borges A; Yui F; Mendes FD; de Nucci G Int J Clin Pharmacol Ther; 2007 Mar; 45(3):175-85. PubMed ID: 17416113 [TBL] [Abstract][Full Text] [Related]
13. Zero-Order Controlled Delivery of Gliclazide from Polyethylene Oxides Matrix Tables: In vitro and In vivo Evaluation. Wang L; Yang X; Di Y; Chen K; Wen H; Pan W Curr Drug Deliv; 2017; 14(1):136-144. PubMed ID: 27000027 [TBL] [Abstract][Full Text] [Related]
14. Bioequivalence of Two Formulations of Gliclazide in a Randomized Crossover Study in Healthy Caucasian Subjects Under Fasting Conditions. Pop DI; Oroian M; Bhardwaj S; Marcovici A; Khuroo A; Kochhar R; Vlase L Clin Pharmacol Drug Dev; 2019 Jan; 8(1):16-21. PubMed ID: 29578647 [TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation and in vivo performance of lyophilized gliclazide. Mansour HF; Aly UF Drug Dev Ind Pharm; 2015 Apr; 41(4):650-7. PubMed ID: 24568609 [TBL] [Abstract][Full Text] [Related]
16. Controlling of systemic absorption of gliclazide through incorporation into alginate beads. Al-Kassas RS; Al-Gohary OM; Al-Faadhel MM Int J Pharm; 2007 Aug; 341(1-2):230-7. PubMed ID: 17507189 [TBL] [Abstract][Full Text] [Related]
17. Comparative in vivo bioequivalence and in vitro dissolution of two cyclosporin A soft gelatin capsule formulations. Avramoff A; Laor A; Kitzes-Cohen R; Farin D; Domb AJ Int J Clin Pharmacol Ther; 2007 Feb; 45(2):126-32. PubMed ID: 17323793 [TBL] [Abstract][Full Text] [Related]
18. Liquid chromatography--mass spectrometry method for the determination of gliclazide in human plasma and application to a pharmacokinetic study of gliclazide sustained release tablets. Wang CY; Zhang W; Xiang BR; Yu LY; Ma PC Arzneimittelforschung; 2008; 58(12):653-8. PubMed ID: 19202737 [TBL] [Abstract][Full Text] [Related]
19. [Medication of the month. Gliclazide modified release (Uni Diamicron)]. Scheen AJ Rev Med Liege; 2003 Oct; 58(10):641-5. PubMed ID: 14677526 [TBL] [Abstract][Full Text] [Related]
20. Effect of binary and ternary solid dispersions on the in vitro dissolution and in-situ rabbit intestinal absorption of gliclazide. El-Maghraby GM; Alomrani AH Pak J Pharm Sci; 2011 Oct; 24(4):459-68. PubMed ID: 21959805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]